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Atherosclerosis is a leading cause of morbidity and mortality in the Western world. The initial hallmark of atheroscle-
rotic lesion development is endothelial dysfunction, and one of 
the main triggers is luminal flow alteration.1 As a result, vessel 
bifurcations and vessel curvatures2 are predilection sites for the 
development of lesions because of natural disturbance of laminar 
flow. Here, molecular changes in the endothelium may indicate 
whether alterations in perfusion are of pathological relevance.3,4 
Therefore, the identification of specific early stage biomarkers 
in combination with an easy accessible, radiation-free, noninva-
sive, and cheap diagnostic method is of high importance.
An increased risk of plaque development is associated 
with elevated serum levels of circulating cytokines, such as 
tumor necrosis factor-α, interleukin-6, and C-reactive protein. 
However, these are unspecific disease markers elevated in 
multiple pathologies and therefore cannot be used for specific 
diagnosis of early atherosclerosis. Consequently, monitoring 
the upregulation of membrane-bound surface adhesion mol-
ecules, like cell adhesion molecules and selectins,5 by molecu-
lar imaging techniques represents a promising approach. In 
the past decade, advances in molecular targeting of endothe-
lial lesions in big and small arteries have been achieved using 
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Objective—The junctional adhesion molecule A (JAM-A) is physiologically located in interendothelial tight junctions and 
focally redistributes to the luminal surface of blood vessels under abnormal shear and flow conditions accompanying 
atherosclerotic lesion development. Therefore, JAM-A was evaluated as a target for molecularly targeted ultrasound 
imaging of transient endothelial dysfunction under acute blood flow variations.
Approach and Results—Flow-dependent endothelial dysfunction was induced in apolipoprotein E–deficient mice (n=43) 
by carotid partial ligation. JAM-A expression was investigated by molecular ultrasound using antibody-targeted poly(n-
butyl cyanoacrylate) microbubbles and validated with immunofluorescence. Flow disturbance and arterial remodeling 
were assessed using functional ultrasound. Partial ligation led to an immediate drop in perfusion at the ligated side and a 
direct compensatory increase at the contralateral side. This was accompanied by a strongly increased JAM-A expression 
and JAM-A–targeted microbubbles binding at the partially ligated side and by a moderate and temporary increase in the 
contralateral artery (≈14× [P<0.001] and ≈5× [P<0.001] higher than control, respectively), both peaking after 2 weeks. 
Subsequently, although JAM-A expression and JAM-A–targeted microbubbles binding persisted at a higher level at the 
partially ligated side, it completely normalized within 4 weeks at the contralateral side.
Conclusions—Temporary blood flow variations induce endothelial rearrangement of JAM-A, which can be visualized 
using JAM-A–targeted microbubbles. Thus, JAM-A may be considered as a marker of acute endothelial activation and 
dysfunction. Its imaging may facilitate the early detection of cardiovascular risk areas, and it enables the therapeutic 
prevention of their progression toward an irreversible pathological state.
Visual Overview—An online visual overview is available for this article.  (Arterioscler Thromb Vasc Biol. 2018;38:40-48. 
DOI: 10.1161/ATVBAHA.117.309503.)
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different diagnostic probes recognizing activated endothelial 
cells, such as targeted phospholipid-based micelles6 for mag-
netic resonance imaging and ligand-modified microbubbles7,8 
for molecular ultrasound imaging. Molecular ultrasound was 
introduced as an extension of conventional ultrasound imag-
ing,9 which is capable of quantifying flow velocity and back 
flow within major arteries, providing anatomic and functional 
data, but which lacks information at the molecular level.10 
Prominent inflammation biomarkers, such as intercellular 





,14 have already been evaluated for 
molecular diagnosis of different stages of atherosclerosis15–18 
by using targeted radiotracers,6 liposomes,19 and microbub-
bles.8 However, early detection of active endothelial sites 
remains challenging for many targets because of their con-
stitutive luminal availability,11,20,21 transient upregulation,11,20,21 
target access,22,23 or partial solubility.24 Therefore, consensus 
toward the clinical translation has not yet been found.25
Nevertheless, junctional adhesion molecule A (JAM-A) 
has been recently involved in molecular imaging protocols 
using targeted ultra-small iron oxide particles nanoparticles 
and microbubbles.26 JAM-A proved to be the biological marker 
most responsive to acute changes in blood flow,27 being upregu-
lated specifically on endothelial cells at the flow-dependent 
predilection sites of atherosclerosis,28 which are responsible for 
monocyte recruitment and accumulation in the vascular wall.27 
Junctional adhesion molecules are members of an immuno-
globulin subclass, which under nonpathological conditions are 
located in the tight junctions of endothelial and epithelial cells,29 
inaccessible from the lumen. Recent studies have shown redis-
tribution of JAM-A to the luminal surface consequent to inflam-
matory stimuli and endothelial activation and have uncovered 
a pivotal role for JAM-A in leukocyte recruitment and trans-
migration.30,31 Furthermore, it was found that the knockout of 
endothelial JAM-A impairs leukocyte migration and confers 
atheroprotective effects.30 JAM-A has an important role in leu-
kocyte recruitment on early atherosclerotic endothelium,30 by 
supporting endothelial deposition of CC-chemokine ligand 
5 from activated platelets.31 It also modulates the function of 
C-X-C-chemokine receptor type 4–bearing hematopoietic stem 
cells by direct interaction.32 Both facts support the suggestion of 
JAM-A as an early atherosclerotic lesion marker.
The aim of our study was to evaluate JAM-A as a target 
for molecular ultrasound imaging of transient endothelial acti-
vation under acute blood flow variations. Therefore, we used 
JAM-A–targeted poly(n-butyl cyanoacrylate) microbubbles 
(MB
JAM-A
) as a contrast agent for molecular ultrasound imag-
ing in a mouse model of flow-induced endothelial activation 
followed by atherosclerotic plaque development. We found 
that MB
JAM-A
 bound specifically to JAM-A on activated endo-
thelium and were able to identify the location of areas with 
endothelial dysfunction. Furthermore, our data show that not 
only flow reduction because of vessel obstruction but also 
flow increase because of compensatory blood flow redistribu-
tion in the contralateral carotid induce luminal exposure of 
JAM-A, both illustrating the high sensitivity of this marker for 
assessing acute vascular vulnerability and remodeling.
Materials and Methods
Materials and Methods are available in the online-only Data 
Supplement.
Results
Analysis of the Binding Affinity of MBJAM-A In Vitro
The number of bound microbubbles was determined using 
fluorescence microscopy (Figure 1A–1E), showing that 
MB
JAM-A
 bound ≈7× more (P<0.0001) to stimulated human 
aortic endothelial cells than to unstimulated cells (Figure 1F) 
and ≈7× more (P<0.0001) than nontargeted control microbub-
bles. There was no significant difference between the binding 
efficiency of control nontargeted microbubbles (Figure 1F) 
and MB
JAM-A
 on unstimulated human aortic endothelial cells, 
showing the binding specificity of the MB
JAM-A
. Moreover, the 
binding specificity of MB
JAM-A
 was confirmed by the competi-
tive binding studies (Figure 1F).
Molecular Ultrasound Imaging of 
JAM-A Expression in Carotid Arteries 
in the Partial Ligation Model
The specificity of MB
JAM-A
 binding was confirmed 2 weeks 
after partial ligation by the absence of control nontargeted 
microbubbles retention and by competitive binding experi-
ments using a 20-fold higher concentration of free anti–JAM-
A antibody administered before MB
JAM-A
 injection. Compared 
with normal binding conditions, blocking JAM-A leads to a 
reduction of MB
JAM-A
 binding by 94% (P=0.0008).
The longitudinal assessment of JAM-A expression by 
molecular ultrasound revealed a slightly enhanced binding 
of MB
JAM-A
 to the luminal side of the partially ligated carotid 
at 1 week post-ligation, followed by a strong increase after 2 
weeks (P=0.0009). Subsequently, MB
JAM-A
 binding decreased 
to a stable level at 3 (P=0.0002) and 4 (P=0.0016) weeks post-
ligation (Figure 2A). Interestingly, JAM-A upregulation was 
also detected in the contralateral carotid 2 weeks after par-
tial ligation (P=0.028), followed by a significant decrease in 
MB
JAM-A
 binding at the 3 weeks time point (P=0.02) and a nor-
malization 4 weeks post-intervention (Figure 2B). In sham-
operated mice at 2 weeks post-intervention, the ultrasound 
signal generated by MB
JAM-A
 was comparable to the mice 
before partial ligation, which indicates that the opening of the 
skin and the mobilization of the artery did not induce JAM-A 
translocation to the luminal surface of the endothelium.
Immunofluorescence of Carotid Arteries 
in the Partial Ligation Model
To determine the expression pattern and localization of JAM-A 
during endothelial activation and plaque development, JAM-A 
and platelet endothelial cell adhesion molecule 1 were stained 
at 1, 2, 3 and 4 weeks post-surgery (Figure 2C). One week 
after partial ligation of the left carotid artery, only focal areas 
Nonstandard Abbreviations and Acronyms
JAM-A junctional adhesion molecule A
MBJAM-A JAM-A–targeted microbubbles
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of endothelia with JAM-A upregulation could be observed 
compared with sham animals. By week 2, JAM-A expression 
was strongly increased in both the endothelial and subendo-
thelial layer, reaching a peak in luminal translocation.
Despite the lack of ligation (but in line with molecular 
ultrasound) also in the right carotid artery, an upregulation and 
luminal exposure of JAM-A were found 2 weeks after liga-
tion of the left carotid artery (Figure 2D), which subsequently 
decreased reaching baseline levels 4 weeks post-surgery.
Morphological and Functional Measures of Arterial 
Remodeling in the Partial Ligation Model
To investigate the accompanying effects of JAM-A upregu-
lation in both left and right carotid arteries, vascular wall 
thickness was quantified by ultrasound measurements. The 
vascular wall thickness in the ligated carotid artery con-
tinuously increased over the experimental period with most 
pronounced changes at the early time points (Figure 3A), indi-
cating a progressive luminal stenosis (Figure 3B). Along with 
the plaque development and arterial narrowing, a decreased 
undulation of the vascular wall was observed, as shown by the 
quantification of lumen variation during systole and diastole 
(Figure 3C).
Interestingly, also in the contralateral carotid, a significant 
increase (P<0.05) in arterial wall thickness was observed 2 
weeks after partial ligation, which, however, did not further 
progress at later time points (Figure 3D). In addition, this 
increase was not associated with a narrowing of the vessel 
lumen (Figure 3E) or a change in arterial wall undulation dur-
ing heart activity (data not shown).
Blood flow assessed by Doppler ultrasound was reduced 
by 56% to 69% over the timespan of 4 weeks in the left carotid 
artery post-ligation (Figure 4). As a compensatory response, 
the blood flow in the right carotid artery increased reaching a 
stable value after 3 weeks, suggesting a hemodynamic adjust-
ment of the blood flow after partial ligation.
Inflammatory Serum Markers 
After Partial Ligation
To determine whether hemodynamic changes induce systemic 
inflammation and vascular vulnerability, inflammation mark-
ers and immune cell content of blood samples were quantified 
at different time points. The absolute numbers of leukocytes, 
neutrophils, monocytes, and lymphocytes did not significantly 
vary during the experiments (Table 1). Moreover, general 
inflammatory and anti-inflammatory markers, such as inter-
feron γ, tumor necrosis factor α, granulocyte-macrophage 
colony-stimulating factor, interleukin-1b, -2, -4, -5, -6, -10, 
-12, -13, and -17, did not show significant changes in serum 
of the mice at any time point after partial ligation (Table 2), 
indicating the absence of systemic inflammatory condition.
JAM-A and Interleukin-6 Gene Expression 
in Carotid Arteries After Partial Ligation
Two weeks postpartial ligation, the JAM-A mRNA level in 
the ligated artery increased (P<0.002) when compared with 
Figure 1. Binding affinity of junctional adhesion molecule A–targeted microbubbles (MBJAM-A) in vitro. MBJAM-A bound ≈7× more (P<0.0001) 
to stimulated human aortic endothelial cells (A and F) than to unstimulated cells (B and F) and ≈7× more (P<0.0001) than control nontar-
geted microbubbles (MBCTR; D and F). There was no significant difference between the binding efficiency of MBCTR (E and F) and MBJAM-A 
(B and F) on unstimulated human aortic endothelial cells. The competitive binding studies (C) showed the specificity of MBJAM-A to stimu-
lated human aortic endothelial cells (scale bar, 100 µm). LDL indicates low-density lipoprotein.
Curaj et al  Molecular Ultrasound Imaging of JAM-A  43
Figure 2. Quantification of junctional adhesion molecule A (JAM-A) after partial ligation. A, Ultrasound data analysis of JAM-A–targeted 
microbubbles (MBJAM-A) binding in the partially ligated artery (n=23) compared with control (pre-operation) and competition (Comp) condi-
tions. The MBJAM-A binding in the left partially ligated carotid artery reaches a peak after 2 wk followed by a rapid decline (****P<0.001).  
B, The corresponding ultrasound signal detected in the contralateral artery (n=23) indicated also a transient increase of MBJAM-A binding  
2 wk post-partial ligation, which was also in line with the immunofluorescence (**P<0.01, ***P<0.001). MB adhesion assays were analyzed 
using the 1-way ANOVA followed by the Newman–Keuls post hoc-test. Error bars represent the SDs. C, Immunofluorescence staining of 
JAM-A (green) in the partially ligated carotid (arrows; n=4/time point) shows the expression of JAM-A on the surface of endothelial cells 
(stained with platelet endothelial cell adhesion molecule 1 [PECAM-1] in red). Nuclear counterstaining is performed with 4’,6-diamidino-
2-phenylindole (DAPI; blue). D, Immunofluorescence staining of JAM-A in the contralateral artery (n=4/time point). L marks the arterial 
lumen (scale bar, 20 µm). MBCTR indicates nontargeted control microbubbles.
44  Arterioscler Thromb Vasc Biol  January 2018
JAM-A mRNA level measured before ligation (Figure 5A). 
The level of interleukin-6 increased (P˂0.001) as well in the 
ligated carotid 2 weeks post-ligature (Figure 5B).
Discussion
In this study, we used JAM-A–targeted poly(n-butyl cya-
noacrylate) microbubbles as contrast agents for molecular 
Figure 3. Arterial remodeling after partial ligation. A, Ultrasound quantification of vessel wall thickness (n=21, n=3–5/time point) revealed 
an initial significant increase 2 wk after partial ligation which peaks at later time points (*P<0.05; ***P<0.001). B, The early growth of an 
atherosclerotic plaque corresponds with a progressive luminal stenosis (****P<0.001). C, The undulation capacity of the vessel decreased 
progressively, along with the plaque development and arterial narrowing (**P<0.01). Representative M-mode images are shown, before 
surgery, 1 and 4 wk post-surgery, as indicated. White arrows indicate the lumen variation during systole (S) and diastole (D). D, Also in 
the contralateral carotid artery (n=21, n=3–5/time point), an increase in thickness of the arterial wall was observed 2 wk post-ligation 
(*P<0.05). However, the lumen of contralateral artery remained stable over the time of the experiment (E). Statistical significance was cal-
culated using the 1-way ANOVA followed by the Newman–Keuls post hoc-test. Error bars represent the SDs.
Figure 4. Blood flow hemodynamic after 
partial ligation. A, Blood flow is reduced 
in the partially ligated artery (white bars) 
while blood flow in the contralateral 
artery adjusts progressively to a higher 
velocity, stabilizing after 3 wk (**P<0.01; 
****P<0.001; n=21, n=3–5/time point). 
Statistical significance was calculated 
using the 1-way ANOVA followed by 
the Newman–Keuls post hoc-test. Error 
bars represent the SDs. B, Representa-
tive ultrasound images of flow velocity in 
carotid arteries before, as well as 2 and  
4 wk after partial ligation.
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ultrasound imaging to identify early inflammatory endothe-
lial sites which may develop toward atherosclerotic areas. 
The luminal availability of JAM-A significantly increased on 
the endothelium after acute decrease in blood flow in the left 
carotid artery because of partial ligation. As a result of the 
flow alteration in the ligated artery and local inflammation, 
atherosclerotic plaque growth was induced, leading to pro-
gressive lumen narrowing. Moreover, atherosclerotic lesion 
formation was associated with an increase in vascular wall 
thickness and a decrease in vascular wall undulations dur-
ing systole and diastole, resembling the characteristics of 
atherosclerotic vessels in humans. The altered undulation of 
the artery points to a decreased vascular elasticity resulting 
from atherosclerotic plaque development and the change in 
matrix deposition to a high content of elastin. Both the thick 
cell-rich atherosclerotic plaque with multiple 4’,6-diamid-
ino-2-phenylindole–stained layers covering the internal elas-
tic lamina and the increased autofluorescence of the elastic 
laminas because of the higher content of elastin33 could be 
observed in the histological slides.
Decreased perfusion and oscillatory flow3 represent a 
major local risk for the development and stability34 of ath-
erosclerotic lesions, and they also induce a low-level inflam-
matory state.35 The onset of plaque growth and endothelial 
activation was sensitively detected using MB
JAM-A
 2 weeks 
after vessel ligation. Although mRNA levels of the systemic 
inflammatory marker interleukin-6 increased 2 weeks post-
partial ligation, no changes were found in the serum over the 
entire timeframe of the experiment. Therefore, we conclude 
that the inflammation was locally restricted. Our results are 
in line with other studies identifying the 2 weeks time period 
as the biologically active time window in the development 
of flow-induced endothelial dysfunction toward athero-
sclerosis.36,37 However, the study of Schmitt et al27 reports 
an upregulation of junctional JAM-A for an experimental 
period of 8 weeks. The prolonged upregulation of junctional 
JAM-A would be interesting to be detected with regular clin-
ical diagnostic modalities and then correlate the results with 
clinical implications. Although, junctional JAM-A cannot 
be evaluated by molecular ultrasound using microbubbles 
because the latter are too big to penetrate into the junctional 
site of the endothelium. The microbubble size only allows 
the visualization of biological markers exposed to the lumi-
nal side of the endothelial cells. Therefore, this advantage 
of was recently used by Zhang et al26 to describe the JAM-A 
upregulation by the endothelium covering vulnerable athero-
sclerotic plaques.
Because of the sudden blood flow restriction in the par-
tially ligated left carotid artery, a redistribution of blood 
flow through the right carotid artery occurs.38,39 This leads to 
Table 1. Immune Cells in Blood at Different Time Points After Partial Ligation
Cell Type
Before Surgery  
(n=4)
After Partial Ligation
P Value1 wk (n=4) 2 wk (n=4) 3 wk (n=4) 4 wk (n=4)
Leukocytes (× 103/µL) 8.0±1.9 6.5±1.2 6.4±1.7 7.9±1.4 6.2±1.3 n.s.
Neutrophils (%) 14±2.2 18±6.7 13±2.4 17±3.9 13±2.7 n.s.
Monocytes (%) 4.8±1.3 5.2±1.3 4.7±0.9 5.2±1.5 3.0±1.4 n.s.
Lymphocytes (%) 76±2.7 71±5.5 75±2.5 72±4.1 79±0.9 n.s.
n.s. indicates nonsignificant.





P Value1 wk (n=4) 2 wk (n=4) 3 wk (n=4) 4 wk (n=4)
IFN-γ 0.2±0.3 0.0±0.0 1.7±3.4 0.0±0.0 0.0±0.1 n.s.
TNF-α 0.4±0.5 0.1±0.1 0.2±0.1 0.5±0.9 0.5±0.3 n.s.
GM-CSF 0.4±0.1 0.3±0.1 0.2±0.1 0.5±0.3 0.3±0.1 n.s.
IL-1b 5.0±8.1 1.3±1.7 3.0±4.9 13.9±22.2 3.7±7.4 n.s.
IL-2 0.0±0.0 0.0±0.0 0.0±0.0 0.9±1.9 0.1±0.3 n.s.
IL-4 5.9±7.9 0.0±0.0 0.0±0.0 12.8±25.6 3.3±6.6 n.s.
IL-5 1.8±1.9 2.4±0.5 1.3±0.8 2.1±2.3 3.2±4.3 n.s.
IL-6 7.0±8.9 7.3±6.3 8.6±8.1 15.8±24.7 14.6±15.8 n.s.
IL-10 7.9±8.5 12.5±17.5 2.7±4.9 10.7±19.0 16.0±21.3 n.s.
IL-12 2.3±3.7 0.9±1.6 0.9±1.9 8.7±12.2 3.6±2.8 n.s.
IL-13 3.3±6.6 5.0±10.0 0.0±0.0 24.2±48.4 0.0±0.0 n.s.
IL-17 3.6±4.4 0.0±0.0 0.0±0.0 1.8±3.1 3.6±4.9 n.s.
GM-CSF indicates granulocyte-macrophage colony-stimulating factor; IFN, interferon; IL, interleukin; n.s., nonsignificant; and TNF, 
tumor necrosis factor.
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a higher perfusion in this vessel, which is accompanied by 
an increased pressure and shear stress. Although we did not 
observe a dilatation of the lumen in the right carotid artery, 
we found a compensatory thickening of the arterial wall as an 
adaptation mechanism to the increased pressure. It has already 
been described by Caro et al40 that high wall shear stress has an 
atheroprotective role but that a sudden change in flow deter-
mining the oscillatory shear stress41 after partial ligation is the 
promotor of atherosclerosis. This explains our findings in the 
contralateral carotid artery, where an acute increase in blood 
flow from normal state to a high state induces a transitory 
endothelial dysfunction which was faithfully detected with 
MB
JAM-A
 (2 weeks postpartial ligation) until the adaptation 
mechanisms was completed (3 weeks postpartial ligation). 
This hypothesis is further supported by the lack of elevated 
systemic inflammatory markers in the serum that would sug-
gest a systemic inflammatory reaction. Thus, we postulate 
that endothelial cells are able to react toward temporal shear 
stress fluctuations35,42 but also to adapt when the blood flow 
stabilizes.42 In this context, JAM-A expression and imaging 
faithfully depict the biochemical changes taking place at the 
endothelial level, highlighting the potential of JAM-A as a 
versatile biochemical marker for endothelial activation. By 
using JAM-A as a biomarker to assess early stages of ath-
erosclerotic plaque formation, molecular ultrasound using 
MB
JAM-A
 may enable the delineation of predisposed areas of 
atherosclerotic plaque development and the alternation in 
the onset and remission of atherosclerosis. The advantage of 
molecular ultrasound is that echography is a radiation-free, 
real-time, cheap, and broadly available diagnostic imaging 
modality. The imaging protocol could be applied to patients 
with cardiovascular disease who experience repeated parox-
ysmic high blood pressure episodes to detect acute activation 
of atherosclerosis-prone sites, and to adapt the medication 
accordingly, to thereby overcome worsening episodes of the 
cardiovascular disease.
Despite these promising results, there is still optimiza-
tion required for the molecular ultrasound method. On the 
one hand, because of the short circulation time and high flow 
conditions, the unspecific binding of the microbubbles to the 
glycocalyx or their internalization by macrophages is low.43 
On the other hand, short circulation times limit the time span 
during which microbubbles can bind to their target. In addi-
tion, because of the physiological high flow conditions in the 
arteries, the retention of microbubbles at the target is relatively 
short, which can make it difficult to investigate larger ves-
sel areas by ultrasound. However, compared with our study 
in mice, a clinical setup would benefit from the larger vessel 
diameters, the higher vessel surface area, and the slower arte-
rial flow. In addition, by using smaller targeting moieties and 
by increasing the number of targeting ligands on the micro-
bubble surface, for example, by microbubble shell function-
alization with dendrimeric spacers,44 the target affinity and 
binding strength of microbubbles could be improved.
Although the applicability of ultrasound is limited to 
segmental body imaging, other imaging modalities, such as 
positron emission tomography, single-photon emission com-
puted tomography, and magnetic resonance imaging, could 
be applied for whole body screening for predilection sites 
of atherosclerosis. In this context, JAM-A–targeted probes 
for positron emission tomography, single-photon emission 
computed tomography, and magnetic resonance imaging 
could be easily generated using the same binding moiety, 
thus highlighting the broad scope of the presented molecular 
imaging approach.
In conclusion, we demonstrate that noninvasive molecular 
ultrasound with MB
JAM-A
 is capable of detecting focal areas 
of transient endothelial activation triggered by the oscilla-
tory blood flow condition. Thus, molecular ultrasound with 
MB
JAM-A
 may have the capacity to indicate predisposed areas 
of atherosclerotic plaque development, the onset of athero-
sclerosis, and its normalization during therapy.
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Highlights
• Junctional adhesion molecule A (JAM-A) expression can faithfully be imaged using molecularly targeted ultrasound imaging.
• Acute blood flow fluctuations in healthy arteries induce transitory endothelial dysfunction leading to temporary JAM-A expression, which can 
be detected with JAM-A–targeted microbubbles.
• JAM-A is a valuable imaging biomarker to assess endothelial activation and dysfunction at early and even reversible stages.
• JAM-A is suggested as a valuable imaging biomarker to assess early stages of atherosclerotic plaque formation.
